Società Italiana di Urologia

Lavori Scientifici

Lavori Scientifici Soci SIU

Questa sessione permetterà ai Soci SIU di caricare nel sito le proprie pubblicazioni.
In questo modo sarà possibile costruire progressivamente un motore di ricerca che consentirà di accedere a tutte le pubblicazioni dei soci SIU, classificate principalmente per autore, argomento e anno.
Lo scopo è di creare un archivio scientifico delle pubblicazioni soci SIU con facilità di accesso e consultazione.

Titolo

Anno

Riviste

Lingue

Tipologie

Nazioni

Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases

Autori: Sciarra A, Bosman C, Schillaci O, Monti M, Di Chiro C, Di Silverio F.

Anno: 2001 Mese: Gennaio

Lavori Scientifici Soci SIU

Clinical evidence of neuroendocrine differentiation in a patient with prostate cancer and bone marrow micrometastases

Distribution of Inflammation, Pre-Malignant lesions, Incidental Carcinoma in Histologically Confirmed Begin Prostatic Hyperpasia: A Retrospective Analysis

Combination Therapy of Ethinyllestradiol an Somotostatin Analogue Reintroduces Objective Clinical Responses and Decreases Chromogranin A in Patients with Androgen Ablation Refractory Prostate Cancer

Clinical understaging in patients with prostate adenocarcinoma submitted to radical prostatectomy: predictive value of serum chromogranin A.

Long-Term Response to Combination Therapy with Estramustine and Somatostatin Analogue in a Patient with Androgen Ablation-Refractory Prostate Cancer

Somatostatin Analogues and Estrogens in the Treatment of Androgen Ablation Refractory Prostate Adenocarcinoma

Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).

CHROMOGRANIN A EXPRESSION IN FAMILIAL VERSUS SPORADIC PROSTATE CANCER

Use of cyclooxygenase-2 inhibitor for prevention of urethral strictures secondary to transurethral resection of the prostate.

Characterization ofCirculating BloodDendriticCell SubsetsDC123þ (Lymphoid) andDC11Cþ (Myeloid) in ProstateAdenocarcinoma Patients

Complete Response to the Combination Therapy with Androgen Blockade and Somatostatin Analogue in a Patient with Advanced Prostate Cancer: Magnetic Resonance Imaging with 1H-Spectroscopy

New Treatment Strategies in the Management of Hormone Refractory Prostate Cancer (HRPC): Only Chemotherapy?

Adjuvant Therapy with Sorafenib in Bone Metastases Bilateral Renal Carcinoma: A Case Report

Inflammation and Chronic Prostatic Diseases:Evidence for a Link?

Chromogranin A and biochemical progression-free survival in prostate adenocarcinomas submitted to radical prostatectomy

Biopsy-Derived Gleason Artifact and Prostate Volume: Experience Using Ten Samples in Larger Prostates

Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer

Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer

Comparison of chromogranin A, insulin-like growth factor 1 and prostate-specific antigen serum markers in prostate adenocarcinoma and benign prostatic hyperplasia

Neoadjuvant Therapy with Sorafenib in Advanced Renal Cell Carcinoma with Vena cava Extension Submitted to Radical Nephrectomy